Friday 26 June 2020

"CBD Vs COVID-19"

studies on CBD and Covid-19. Mycannashop
In a previeus article we had speak about cannabis terpens against Covid-19. Now we examine the first study of that article to understand better, not only, the way CBD can help us with viruses but how CBD act with our bodies for a better health.Lets say that this is another litle pice of the puzzle...



Researchers at the University of Lethbridge say while clinical trials still need to be done, data they’ve been collecting over the past four years shows promise that some cannabis extracts may help in the prevention and treatment of COVID-19.

The researchers of this study, Olga and Igor Kovalchuk have been working with cannabis since 2015, using varieties from around the world to create new hybrids and develop extracts that demonstrate certain therapeutic properties.

"When COVID-19 started, Olga had the idea to revisit our data, and see if we can utilize it for COVID.We were totally stunned at first, and then we were really happy," says Olga.
"It was like a joker card, you know, coronavirus. It just mixes up everybody’s plans," says Olga.

Tuesday 23 June 2020

"EIHA approve plan for CBD & THC studies"

The main hemp industry body in Europe has received a green light from its members to move forward with “unprecedented” studies on cannabidiol and THC as part of a joint novel food authorization application.

An “overwhelming majority” of European Industrial Hemp Association members voted on Monday in favor of “the principles of the special contribution structure” for the group’s joint application for novel food authorization.


EIHA members agreed last year to submit a joint novel foods application with “a range of CBD extracts” to UK and EU authorities, and the association revealed the anticipated scope and costs associated with the joint application last month.

The anticipated cost of the joint application project is going up. EIHA projected that around €3.5 million ($3.9 million) will be invested over the next two to three years in “unprecedented studies” on the toxicology of CBD and THC.

The EIHA previously estimated the cost for the lab analysis of CBD and THC at €1.8 million ($2 million).

Friday 12 June 2020

"CBD Oil for Peripheral Neuropathy"







CBD Oil for Peripheral Neuropathy mycannashop
Neuropathy can affect your overall wellbeing and quality of life. It involves an intense pain that is challenging to manage because it affects the nerves of the peripheral nervous system. 
Patients suffering from neuropathy often use opioids pain medications. Although these medications can be useful in reducing pain, they pose the risk of overdose, addiction, and abuse.
Due to this, most people look for alternative treatments.
CBD is becoming a preferred alternative remedy for patients with neuropathy. This is because its the non-psychoactive component of marijuana that has numerous health benefits. CBD doesn’t produce any side effects and is an appropriate option for patients.
What is Peripheral Neuropathy?
Understanding what Peripheral neuropathy means is important to appreciating the possible remedy that CBD oil brings to the victims. It is a medical disorder that occurs when there is damage to the nerves that link the other body parts such as skin and muscles to the spinal cord and the brain. Damage to these nerves interferes with communication between other parts of the body and the brain. Besides, it reduces sensation in the legs and arms, affects movement and causes pain.
However, the dose matters when it comes to neuropathic pain, and it is crucial to start with small doses and examine their impact on your body before increasing the quantity. Once you get a preferred dosage, stick to it.

Wednesday 3 June 2020

"Cannabis and Cannabinoids. Integrative, alternative, and complementary therapies"


cannabinoids and cancer
Cannabis, also known as marijuana, is a plant grown in many parts of the world. It makes a resin (thick substance) that contains compounds called cannabinoids.

Cannabis and cannabinoids have been studied for relief of pain, nausea and vomiting, anxiety, and loss of appetite caused by cancer or the side effects of cancer therapies.


Cancer patients considering complementary and alternative therapies should discuss this decision with their doctor, nurse, or pharmacist as they would any type of treatment. Some complementary and alternative therapies may affect their standard treatment or may be harmful when used with conventional treatment.

The National Cancer Institute and the National Center for Complementary and Integrative Health (NCCIH) are sponsoring a number of clinical trials (research studies) at medical centers to test CAM therapies for use in cancer.


What are cannabinoids?

Cannabinoids, also known as phytocannabinoids, are chemicals in Cannabis that cause drug-like effects in the body, including the central nervous system and the immune system. The main psychoactive cannabinoid in Cannabis is delta-9-THC.
Another active cannabinoid is cannabidiol (CBD), which may relieve pain and lower inflammation without causing the high of delta-9-THC.Cannabinoids may help treat the side effects of cancer and cancer treatment.